Levamisole Supplier-Buyer Network — Trade Flow Analysis

Name: Levamisole Supplier-Buyer Trade Network Dataset — 72+ Indian Exporters, 8+ Importers, 39+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Levamisole supplier network, Levamisole buyers, pharmaceutical export India, Levamisole trade data

TransData Nexus

Levamisole

India Pharmaceutical Trade Intelligence

$2.7M72 Suppliers39 CountriesHS 30049099

ExportsIndia → SUDAN39.3%India → CONGO DR14.9%

Who Supplies Levamisole? Top Manufacturers & Buyers 2026 — LYKA BDR INTERNATIONAL LIMITED Leads | TransData Nexus | TransData Nexus

1COMBITIC GLOBAL CAPLET PRIVATE LIMITED

COMBITIC GLOBAL CAPLET PRIVATE LIMITED is the first-largest Levamisole exporter from India, with a market share of 12.8% and a total export value of $341.0K across 25 shipments. Their average shipment value of $13.6K is above the market average of $8.2K, suggesting premium or bulk contract pricing.

COMBITIC GLOBAL CAPLET PRIVATE LIMITED serves 4 named buyers in our database. LLC SMART PHARMO is the dominant customer, accounting for 64.8% of this supplier's tracked business. Top customers include:

• LLC SMART PHARMO — $221.1K across 16 shipments (64.8% of this supplier's total exports)

• BIOMEDIKAL LLC — $113.8K across 8 shipments (33.4% of this supplier's total exports)

• SHAMS NOORI PHARMA T — $6.0K across 0 shipments (1.7% of this supplier's total exports)

• KHAN SEHAT LTD — $86 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: COMBITIC GLOBAL CAPLET PRIVATE LIMITED's per-shipment value of $13.6K is 67% above the market average of $8.2K, consistent with large-order contracts or value-added formulations.

2LYKA BDR INTERNATIONAL LIMITED

LYKA BDR INTERNATIONAL LIMITED is the second-largest Levamisole exporter from India, with a market share of 10.7% and a total export value of $283.5K across 11 shipments. Their average shipment value of $25.8K is above the market average of $8.2K, suggesting premium or bulk contract pricing.

LYKA BDR INTERNATIONAL LIMITED serves 2 named buyers in our database. DARVET FOR TRADING & INVESTMENT CO is the dominant customer, accounting for 75.0% of this supplier's tracked business. Top customers include:

• DARVET FOR TRADING & INVESTMENT CO — $212.5K across 8 shipments (75.0% of this supplier's total exports)

• DARVET FOR TRADING & INVESTMENT CO — $71.0K across 3 shipments (25.0% of this supplier's total exports)

Key Insight: LYKA BDR INTERNATIONAL LIMITED's per-shipment value of $25.8K is 215% above the market average of $8.2K, consistent with large-order contracts or value-added formulations.

3LYKA LABS LIMITED

LYKA LABS LIMITED is the third-largest Levamisole exporter from India, with a market share of 4.9% and a total export value of $130.5K across 3 shipments. Their average shipment value of $43.5K is above the market average of $8.2K, suggesting premium or bulk contract pricing.

LYKA LABS LIMITED serves 1 named buyer in our database. HNL GENERAL TRADING LLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• HNL GENERAL TRADING LLC — $130.5K across 3 shipments (100.0% of this supplier's total exports)

Key Insight: LYKA LABS LIMITED's per-shipment value of $43.5K is 431% above the market average of $8.2K, consistent with large-order contracts or value-added formulations.

4DOSCH PHARMACEUTICALS PRIVATE LIMITED

DOSCH PHARMACEUTICALS PRIVATE LIMITED is the fourth-largest Levamisole exporter from India, with a market share of 4.6% and a total export value of $122.1K across 24 shipments. Their average shipment value of $5.1K is below the market average of $8.2K, reflecting a high-volume, competitive pricing strategy.

DOSCH PHARMACEUTICALS PRIVATE LIMITED serves 3 named buyers in our database. NA is the dominant customer, accounting for 68.3% of this supplier's tracked business. Top customers include:

• NA — $83.3K across 16 shipments (68.3% of this supplier's total exports)

• TO THE ORDER — $36.9K across 7 shipments (30.2% of this supplier's total exports)

• TO THE ORDER — $1.8K across 0 shipments (1.5% of this supplier's total exports)

Key Insight: DOSCH PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (24 shipments) at a per-shipment value of $5.1K, indicating a broad distribution network with many smaller, regular orders.

5PRASHI PHARMA PRIVATE LIMITED

PRASHI PHARMA PRIVATE LIMITED is the fifth-largest Levamisole exporter from India, with a market share of 3.7% and a total export value of $99.2K across 15 shipments. Their average shipment value of $6.6K is below the market average of $8.2K, reflecting a high-volume, competitive pricing strategy.

PRASHI PHARMA PRIVATE LIMITED serves 1 named buyer in our database. STE PRINCE PHARMA SARL is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• STE PRINCE PHARMA SARL — $99.2K across 15 shipments (100.0% of this supplier's total exports)

Key Insight: PRASHI PHARMA PRIVATE LIMITED operates with high shipment frequency (15 shipments) at a per-shipment value of $6.6K, indicating a broad distribution network with many smaller, regular orders.

6DIPS BIOSCIENCE PRIVATE LIMITED

DIPS BIOSCIENCE PRIVATE LIMITED is the fifth-largest Levamisole exporter from India, with a market share of 3.6% and a total export value of $95.5K across 4 shipments. Their average shipment value of $23.9K is above the market average of $8.2K, suggesting premium or bulk contract pricing.

DIPS BIOSCIENCE PRIVATE LIMITED serves 2 named buyers in our database. M S is the dominant customer, accounting for 81.7% of this supplier's tracked business. Top customers include:

• M S — $78.0K across 3 shipments (81.7% of this supplier's total exports)

• TO THE ORDER — $17.5K across 1 shipments (18.3% of this supplier's total exports)

Key Insight: DIPS BIOSCIENCE PRIVATE LIMITED's per-shipment value of $23.9K is 191% above the market average of $8.2K, consistent with large-order contracts or value-added formulations.

1Sudan

Sudan ranks as the first-largest destination for Levamisole imports from India, with a total trade value of $1.0M across 14 shipments — representing a 39.3% share of all Levamisole exports. The average shipment value of $74.7K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Levamisole importers in Sudan: HNL GENERAL TRADING LLC is the largest buyer, accounting for 72.9% ($762.3K) of this market's total imports.

• HNL GENERAL TRADING LLC — $762.3K (72.9% of Sudan's total)

• DARVET FOR TRADING & INVESTMENT CO — $212.5K (20.3% of Sudan's total)

• DARVET FOR TRADING INVESTMENT CO — $71.0K (6.8% of Sudan's total)

Key Insight: Sudan's per-shipment average of $74.7K (812% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sudan is a key market for Levamisole imports from India.

Primary Market

Secondary Market

2Congo Dr

Congo Dr ranks as the second-largest destination for Levamisole imports from India, with a total trade value of $397.6K across 20 shipments — representing a 14.9% share of all Levamisole exports. The average shipment value of $19.9K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Levamisole importers in Congo Dr: STE PRINCE PHARMA SARL is the largest buyer, accounting for 47.7% ($189.5K) of this market's total imports.

• STE PRINCE PHARMA SARL — $189.5K (47.7% of Congo Dr's total)

• MEDICO PLUS — $29.0K (7.3% of Congo Dr's total)

Key Insight: Congo Dr's per-shipment average of $19.9K (143% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Congo Dr is a key market for Levamisole imports from India.

Primary Market

Secondary Market

3Uzbekistan

Uzbekistan ranks as the third-largest destination for Levamisole imports from India, with a total trade value of $372.7K across 14 shipments — representing a 14.0% share of all Levamisole exports. The average shipment value of $26.6K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Levamisole importers in Uzbekistan: LLC SMART PHARMO is the largest buyer, accounting for 59.3% ($221.1K) of this market's total imports.

• LLC SMART PHARMO — $221.1K (59.3% of Uzbekistan's total)

• BIOMEDIKAL LLC — $132.5K (35.6% of Uzbekistan's total)

Key Insight: Uzbekistan's per-shipment average of $26.6K (225% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Uzbekistan is a key market for Levamisole imports from India.

Primary Market

Secondary Market

4United Kingdom

United Kingdom ranks as the fourth-largest destination for Levamisole imports from India, with a total trade value of $95.5K across 0 shipments — representing a 3.6% share of all Levamisole exports. The average shipment value of $95.5K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations.

Key Insight: United Kingdom's per-shipment average of $95.5K (1066% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Levamisole imports from India.

Primary Market

Secondary Market

5Chad

Chad ranks as the fifth-largest destination for Levamisole imports from India, with a total trade value of $82.1K across 2 shipments — representing a 3.1% share of all Levamisole exports. The average shipment value of $41.0K is above the global average of $8.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Levamisole importers in Chad: KEBIRVET SARL is the largest buyer, accounting for 43.9% ($36.0K) of this market's total imports.

• KEBIRVET SARL — $36.0K (43.9% of Chad's total)

Key Insight: Chad's per-shipment average of $41.0K (401% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Chad is a key market for Levamisole imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Levamisole.
2.Flow Mapping: 72 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 325 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 39 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

325 Verified Shipments

72 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Levamisole

Levamisole

Who Supplies Levamisole? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Levamisole? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Levamisole Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1COMBITIC GLOBAL CAPLET PRIVATE LIMITED

2LYKA BDR INTERNATIONAL LIMITED

3LYKA LABS LIMITED

4DOSCH PHARMACEUTICALS PRIVATE LIMITED

5PRASHI PHARMA PRIVATE LIMITED

6DIPS BIOSCIENCE PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Levamisole Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Levamisole Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Sudan

2Congo Dr

3Uzbekistan

4United Kingdom

5Chad

People Also Ask — Levamisole Supplier & Trade Network

Levamisole Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology